Naor Bar-Zeev

Associate Professor

Bloomberg School of Public Health

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Naor Bar-Zeev is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

18 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

57 Article
9 Review article
5 Comment/debate
1 Editorial
More
- 1 Letter

Expecting the unexpected with COVID-19 vaccines
Bar-Zeev, N. & Kochhar, S., Feb 2021, In: The Lancet Infectious Diseases. 21, 2, p. 150-151 2 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: The Antibiotics for Children with Diarrhoea (ABCD) trial protocol
Alam, T., Ahmed, D., Ahmed, T., Chisti, M. J., Rahman, M. W., Asthana, A. K., Bansal, P. K., Chouhan, A., Deb, S., Dhingra, P., Dhingra, U., Dutta, A., Jaiswal, V. K., Kumar, J., Pandey, A., Sazawal, S., Sharma, A. K., McGrath, C., Nyabinda, C., Okello, M. & 36 others, Pavlinac, P. B., Singa, B., Walson, J. L., Bar-Zeev, N., Dube, Q., Freyne, B., Ndamala, C., Ndeketa, L., Badji, H., Booth, J. P., Coulibaly, F., Haidara, F., Kotloff, K., Malle, D., Mehta, A., Sow, S., Tapia, M., Tennant, S., Hotwani, A., Kabir, F., Qamar, F., Qureshi, S., Shakoor, S., Thobani, R., Yousufzai, M. T., Bakari, M., Duggan, C., Kibwana, U., Kisenge, R., Manji, K., Somji, S., Sudfeld, C., Ashorn, P., Bahl, R., De Costa, A. & Simon, J., Jan 13 2020, In: Trials. 21, 1, 71.
Research output: Contribution to journal › Article › peer-review

Open Access
Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
Pecenka, C., Debellut, F., Bar-Zeev, N., Anwari, P., Nonvignon, J. & Clark, A., Feb 5 2020, In: Vaccine. 38, 6, p. 1277-1279 3 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
COVID-19 vaccines: early success and remaining challenges
Bar-Zeev, N. & Inglesby, T., Sep 26 2020, In: The Lancet. 396, 10255, p. 868-869 2 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Differential COVID-19-attributable mortality and BCG vaccine use in countries
Shet, A., Ray, D., Malavige, N., Santosham, M. & Bar-Zeev, N., Apr 6 2020, In: Unknown Journal.
Research output: Contribution to journal › Article › peer-review

Expecting the unexpected with COVID-19 vaccines

A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: The Antibiotics for Children with Diarrhoea (ABCD) trial protocol

Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?

COVID-19 vaccines: early success and remaining challenges

Differential COVID-19-attributable mortality and BCG vaccine use in countries